Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
Trump's pick for HHS secretary who endured confirmation hearings last week—has repeatedly criticized industry ties to the FDA ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
22h
Pharmaceutical Technology on MSNFDA grants orphan drug status to Arbor Biotechnologies’ PH1The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
But the medication’s modest effectiveness and lengthy development process underscore ... Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
But the medication’s modest effectiveness and lengthy development process underscore ... Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across ...
9d
Verywell Health on MSNSpravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results